000 | 03416nam a22006495i 4500 | ||
---|---|---|---|
001 | 978-3-031-69162-1 | ||
003 | DE-He213 | ||
005 | 20250516160149.0 | ||
007 | cr nn 008mamaa | ||
008 | 241015s2024 sz | s |||| 0|eng d | ||
020 |
_a9783031691621 _9978-3-031-69162-1 |
||
050 | 4 | _aR850.A1-854 | |
050 | 4 | _aQH315-320 | |
072 | 7 |
_aMBGR _2bicssc |
|
072 | 7 |
_aMED106000 _2bisacsh |
|
072 | 7 |
_aMBGR _2thema |
|
082 | 0 | 4 |
_a610.72 _223 |
245 | 1 | 0 |
_aStructure-Based Drug Design _h[electronic resource] / _cedited by Marcelo A. Marti, Adrian Gustavo Turjanski, Dario Fernández Do Porto. |
250 | _a1st ed. 2024. | ||
264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2024. |
|
300 |
_aIX, 256 p. 80 illus., 70 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aComputer-Aided Drug Discovery and Design, _x2730-5465 ; _v2 |
|
505 | 0 | _aPrioritizing Drug Targets in Pathogenic Bacteria by Harnessing Structural Biology, Metabolic Analysis, and Omics Data Integration -- Regulatory small RNAs as antimicrobial drug targets -- Riboswitches as antimicrobial targets -- Pre-selection of compounds for lead identification in virtual screening campaigns -- Docking and Bias Docking -- Molecular Dynamics and its Significance in Drug Discovery -- Deep Learning Strategies for Enhanced Molecular Docking and Virtual Screening -- Integrating computational approaches from non-synonymous sequence variations to molecular structure for drug repositioning targeting the SARS-CoV-2 Spike protein. | |
520 | _aThis volume focuses on target-oriented approximations to drug discovery, including target selection, binding pocket detection, and current uses and variants of molecular dynamics and molecular docking. The primary audience is PhD and graduates working in the field of molecular biology, structural biology, pharmaceutical sciences. | ||
541 |
_fUABC ; _cPerpetuidad |
||
650 | 0 |
_aMedicine _xResearch. |
|
650 | 0 |
_aBiology _xResearch. |
|
650 | 0 | _aPharmacology. | |
650 | 0 |
_aDrugs _xDesign. |
|
650 | 0 | _aPharmaceutical chemistry. | |
650 | 0 | _aPharmacy. | |
650 | 1 | 4 | _aBiomedical Research. |
650 | 2 | 4 | _aPharmacology. |
650 | 2 | 4 | _aStructure-Based Drug Design. |
650 | 2 | 4 | _aPharmaceutics. |
650 | 2 | 4 | _aPharmacy. |
700 | 1 |
_aMarti, Marcelo A. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aTurjanski, Adrian Gustavo. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aFernández Do Porto, Dario. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer Nature eBook | |
776 | 0 | 8 |
_iPrinted edition: _z9783031691614 |
776 | 0 | 8 |
_iPrinted edition: _z9783031691638 |
776 | 0 | 8 |
_iPrinted edition: _z9783031691645 |
830 | 0 |
_aComputer-Aided Drug Discovery and Design, _x2730-5465 ; _v2 |
|
856 | 4 | 0 |
_zLibro electrónico _uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-3-031-69162-1 |
912 | _aZDB-2-SBL | ||
912 | _aZDB-2-SXB | ||
942 | _cLIBRO_ELEC | ||
999 |
_c276659 _d276658 |